Search results for " Cancer"

showing 10 items of 6120 documents

Titanocene–gold complexes containing N-heterocyclic carbene ligands inhibit growth of prostate, renal, and colon cancers in vitro

2016

We report on the synthesis, characterization, and stability studies of new titanocene complexes containing a methyl group and a carboxylate ligand (mba = −OC(O)-p-C6H4-S−) bound to gold(I)−N-heterocyclic carbene fragments through the thiolate group: [(η5 -C5H5)2TiMe(μ-mba)Au(NHC)]. The cytotoxicities of the heterometallic compounds along with those of novel monometallic gold−N-heterocyclic carbene precursors [(NHC)Au(mbaH)] have been evaluated against renal, prostate, colon, and breast cancer cell lines. The highest activity and selectivity and a synergistic effect of the resulting heterometallic species was found for the prostate and colon cancer cell lines. The colocalization of both tita…

010405 organic chemistryLigandStereochemistryOrganic Chemistry010402 general chemistrymedicine.disease01 natural sciencesArticleIn vitro3. Good health0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundProstate cancermedicine.anatomical_structurechemistryProstatemedicineCarboxylatePhysical and Theoretical ChemistryQD0146SelectivityCarbeneMethyl group
researchProduct

Synthesis and in vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. Part 2

2017

On the basis of high-throughput screening, fragment-based drug discovery, structure–activity relationships and building block analysis methods, herein we report the synthesis and biological evaluation of a novel series of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives. All of the prepared Schiff bases (with mono-, di- and poly-substituents at the aromatic portion), mono- and bis-amides of diethyl 2,5-diaminothiophene-3,4-dicarboxylate, were evaluated against various human cancer and non-cancerous (only for active compounds) cell lines, as well as influenza A (subtypes FM/1/47/H1N1, hanfang/359/95/H3N2) and B (subtype jifang/13/97) viruses. The obtained results suggest that some …

010405 organic chemistryStereochemistryDrug discoveryChemistryGeneral Chemical EngineeringInfluenza aGeneral Chemistry010402 general chemistry01 natural sciencesIn vitroVirus0104 chemical sciencesCell cultureHuman cancerAnalysis methodBiological evaluationRSC Advances
researchProduct

GRB 050904 at redshift 6.3: observations of the oldest cosmic explosion after the Big Bang

2005

We present optical and near-infrared observations of the afterglow of the gamma-ray burst GRB 050904. We derive a photometric redshift z = 6.3, estimated from the presence of the Lyman break falling between the I and J filters. This is by far the most distant GRB known to date. Its isotropic-equivalent energy is 3.4x10^53 erg in the rest-frame 110-1100 keV energy band. Despite the high redshift, both the prompt and the afterglow emission are not peculiar with respect to other GRBs. We find a break in the J-band light curve at t_b = 2.6 +- 1.0 d (observer frame). If we assume this is the jet break, we derive a beaming-corrected energy E_gamma = (4-12)x10^51 erg. This limit shows that GRB 050…

010504 meteorology & atmospheric sciencesgamma rays: burstsAstrophysics::High Energy Astrophysical PhenomenaFOS: Physical sciencesAstrophysicsAstrophysics::Cosmology and Extragalactic AstrophysicsJet (particle physics)Astrophysics01 natural sciences[PHYS.ASTR.CO]Physics [physics]/Astrophysics [astro-ph]/Cosmology and Extra-Galactic Astrophysics [astro-ph.CO]gamma rays: individual: GRB 0509040103 physical sciences010303 astronomy & astrophysics0105 earth and related environmental sciencesPhotometric redshiftPhysicsCOSMIC cancer database[SDU.ASTR]Sciences of the Universe [physics]/Astrophysics [astro-ph]Star formationAstrophysics (astro-ph)Astronomy and Astrophysicsearly UniverseLight curveRedshiftAfterglowSpace and Planetary Sciencecosmology: observationsGamma-ray burst
researchProduct

Novel simple templates for reproducible positioning of skin applicators in brachytherapy.

2016

Purpose : Esteya and Valencia surface applicators are designed to treat skin tumors using brachytherapy. In clinical practice, in order to avoid errors that may affect the treatment outcome, there are two issues that need to be carefully addressed. First, the selected applicator for the treatment should provide adequate margin for the target, and second, the applicator has to be precisely positioned before each treatment fraction. In this work, we describe the development and use of a new acrylic templates named Template La Fe-ITIC. They have been designed specifically to help the clinical user in the selection of the correct applicator, and to assist the medical staff in reproducing the po…

0106 biological sciencesEngineering drawingmedicine.medical_specialtyMedical staffelectronic brachytherapymedicine.medical_treatmentTreatment outcomeBrachytherapybrachytherapylcsh:Medicine01 natural sciences03 medical and health sciences0302 clinical medicineMargin (machine learning)medicineRadiology Nuclear Medicine and imagingMedical physicsReview Paperskin cancerbusiness.industrylcsh:RtemplateThin sheetClinical Practiceskin applicatorsTemplateOncology030220 oncology & carcinogenesisbusiness010606 plant biology & botanyJournal of contemporary brachytherapy
researchProduct

The Potential Role of Medicinal Mushrooms in the Prevention and Treatment of Gynecological Cancers: A Review

2019

A review of scientific information about the potential role of medicinal mushrooms in the prevention and treatment of gynecological cancers, human immunodeficiency virus, and human papillomavirus infections is reported here. The results of in vivo and in vitro experiments on 16 different species of Basidiomycetes and three Ascomycetes, which possess chemopreventive potential and are effective in clinical application in combination with chemotherapy, are also discussed. Medicinal mushroom extracts confirm an evident efficacy on the reduction of tumor cell proliferation and side effects in patients with gynecological tumors who are undergoing chemotherapy treatments. This review, the first on…

0106 biological sciencesanimal structuresVaginal NeoplasmsGenital Neoplasms Femalemedicine.medical_treatmentHuman immunodeficiency virus (HIV)Uterine Cervical NeoplasmsTumor cellsmedicine.disease_cause01 natural sciencesApplied Microbiology and BiotechnologyAntioxidantsMiceMedicinal mushroomAscomycotaIn vivo010608 biotechnologyDrug DiscoverymedicineAnimalsHumansIn patientHuman papillomavirusPapillomaviridaeCell ProliferationPharmacologyChemotherapyBiological ProductsClinical Trials as Topicbusiness.industryBasidiomycotafungiHIVSettore BIO/03 - Botanica Ambientale E ApplicataCancer researchFemalebusinessAgaricalesmedicinal mushrooms gynecological cancers human immunodeficiency virus human papillomavirus Basidiomycetes Ascomycetes
researchProduct

OMICfpp: a fuzzy approach for paired RNA-Seq counts

2019

© The Author(s) 2019.

0106 biological scienceslcsh:QH426-470Pipeline (computing)lcsh:BiotechnologyRNA-SeqBinomial testSample (statistics)Biologyoncología médicaMedical Oncology01 natural sciencesFuzzy logicSet (abstract data type)03 medical and health sciencesUser-Computer InterfaceSoftwarelcsh:TP248.13-248.65GeneticsHumansCàncer030304 developmental biologyOrdered weight average0303 health sciencesbusiness.industrySequence Analysis RNAMethodology ArticleHigh-Throughput Nucleotide SequencingPattern recognitionColorectal cancerlcsh:Genetics3201.01 OncologíatranscriptomaRandomization distributionRNAArtificial intelligenceDNA microarraybusinessColorectal NeoplasmsTranscriptome010606 plant biology & botanyBiotechnology
researchProduct

Erratum to “Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy”

2018

03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesis030211 gastroenterology & hepatologyErratumlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282Case Reports in Oncological Medicine
researchProduct

Proteome Analysis of Colorectal Cancer Cell Line SW480 Released Extracellular Vesicles

2018

The detection and profiling of disease-specific extracellular vesicles (EVs) from body fluids has been challenging research area during recent years. However, the question – can EVs surface proteins be exploited as a credible tool for early cancer diagnosis – is still not answered. Objective of the current study was to find out whether hypoxia induces differences in protein profiles of EVs released from hypoxic human colorectal cancer cells SW480 (EVHyp) and EVs released from these cells grown in normoxic conditions – EVNorm. Obtained results show differences in EVs surface protein samples. Some protein fragments were found only or mostly in EVHyp surface protein samples. Finding of one or …

0301 basic medicine03 medical and health sciences030104 developmental biologyMechanics of MaterialsChemistryMechanical EngineeringProteomeGeneral Materials ScienceProtein profileColorectal cancer cell lineExtracellular vesiclesMicrovesiclesCell biologyKey Engineering Materials
researchProduct

Decline in the incidence of colorectal cancer and the associated mortality in young Italian adults

2020

Objective The incidence of colorectal cancer (CRC) declines among subjects aged 50 years and above. An opposite trend appears among younger adults. In Europe, data on CRC incidence among younger adults are lacking. We therefore aimed to analyse European trends in CRC incidence and mortality in subjects younger than 50 years. Design Data on age-related CRC incidence and mortality between 1990 and 2016 were retrieved from national and regional cancer registries. Trends were analysed by Joinpoint regression and expressed as annual percent change. Results We retrieved data on 143.7 million people aged 20–49 years from 20 European countries. Of them, 187 918 (0.13%) were diagnosed with CRC. On a…

0301 basic medicine2312ColonPopulationSocio-culturalecolorectal cancercolorectal cancer screening03 medical and health sciencesYoung Adult0302 clinical medicineEpidemiology of cancerMedicineHumans1506Risk factoreducationeducation.field_of_studycancer epidemiology Colorectal cancer colorectal cancer screeningbusiness.industryIncidence (epidemiology)Mortality ratescreeningIncidenceGastroenterologyCancermedicine.diseaseObesityAnnual Percent ChangeEurope030104 developmental biologyItaly030211 gastroenterology & hepatologyepidemiologybusinessColorectal NeoplasmsDemographycancer epidemiologySEER Program
researchProduct

2,3-Dihydrobenzofuran privileged structures as new bioinspired lead compounds for the design of mPGES-1 inhibitors

2016

International audience; 2,3-Dihydrobenzofurans are proposed as privileged structures and used as chemical platform to design small compound libraries. By combining molecular docking calculations and experimental verification of biochemical interference, we selected some potential inhibitors of microsomal prostaglandin E2 synthase (mPGES)-1. Starting from low affinity natural product 1, by our combined approach we identified the compounds 19 and 20 with biological activity in the low micromolar range. Our data suggest that the 2,3-dihydrobenzofuran derivatives might be suitable bioinspired lead compounds for development of new generation mPGES-1 inhibitors with increased affinity.

0301 basic medicine300323-Dihydrobenzofuran privileged structure; Cancer; Inflammation; Molecular docking; mPGES-1 inhibitors; Biochemistry; Clinical Biochemistry; Molecular Biology; Molecular Medicine; Organic Chemistry; Drug Discovery3003 Pharmaceutical Science; 3003Amino Acid MotifsClinical BiochemistryGene ExpressionPharmaceutical Science01 natural sciencesClinical biochemistryBiochemistry[ CHIM ] Chemical SciencesProtein Structure Secondary[ SDV.CAN ] Life Sciences [q-bio]/Cancerchemistry.chemical_compoundLow affinityDrug DiscoveryEnzyme Inhibitors23-Dihydrobenzofuran privileged structure; Molecular docking; mPGES-1 inhibitors; Cancer; InflammationProstaglandin-E SynthasesCancerAnti-Inflammatory Agents Non-SteroidalBiological activityProto-Oncogene Proteins c-metIntramolecular OxidoreductasesMolecular Docking SimulationMolecular dockingMolecular Medicinelipids (amino acids peptides and proteins)Cell SurvivalStereochemistryMolecular Sequence Data2Antineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/Cancer3-Dihydrobenzofuran privileged structureInhibitory Concentration 50Structure-Activity Relationship03 medical and health sciencesCell Line TumorMicrosomesHumans[CHIM]Chemical SciencesMolecular BiologyBenzofuransInflammationNatural product010405 organic chemistryDrug Discovery3003 Pharmaceutical ScienceOrganic ChemistryEpithelial CellsmPGES-1 inhibitorsCombinatorial chemistryCombined approach0104 chemical sciences030104 developmental biologychemistryDrug DesignDrug Screening Assays Antitumor
researchProduct